TipRanks
Go Ultimate55% OFF

Lakefront Biotherapeutics NV (0JXZ) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0JXZ Analyst Ratings

Moderate Sell
2Ratings
0Buy1Hold1Sell
Based on 2 analysts giving stock ratings to Lakefront Biotherapeutics NV in the past 3 months

0JXZ Stock 12 Month Forecast

EUR 24.95▼(-13.37% Downside)
Based on 2 Wall Street analysts offering 12 month price targets for Lakefront Biotherapeutics NV in the last 3 months. The average price target is EUR 24.95 with a high forecast of EUR 27.90 and a low forecast of EUR 22.00. The average price target represents a -13.37% change from the last price of EUR 28.80.
Highest Price TargetEUR 27.90Average Price TargetEUR 24.95Lowest Price TargetEUR 22.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0JXZ
Price TargetFollowArticle
BarclaysEUR 22sell-23.61%DownsideReiterated09/08/26
BernsteinEUR 27.90hold-3.13%DownsideReiterated09/01/26
Kepler Capital EUR 23.50sell-18.40%DownsideReiterated05/07/26
UBSEUR 30hold4.17%UpsideReiterated04/01/26
Bank of America Securities―sell―Reiterated11/07/25
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Lakefront Biotherapeutics NV

3 Months
Christophe dombu
Christophe dombuKepler Capital
Success Rate6/12 ratings generated profit
50%
Average Return
-2.89%

Copying Christophe dombu's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -2.89% per trade.

1 Year
Christophe dombu
Christophe dombuKepler Capital
Success Rate3/12 ratings generated profit
25%
Average Return
-5.64%

Copying Christophe dombu's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -5.64% per trade.

2 Years
Christophe dombu
Christophe dombuKepler Capital
Success Rate2/12 ratings generated profit
17%
Average Return
-13.98%

Copying Christophe dombu's trades and holding each position for 2 Years would result in 16.67% of your transactions generating a profit, with an average return of -13.98% per trade.

0JXZ Analyst Recommendation Trends

02468Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 0JXZ
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy00000
Hold00111
Sell21221
Strong Sell00000
total21332

In the current month, 0JXZ has received 0 Buy Ratings, 1 Hold Ratings, and 1 Sell Ratings. 0JXZ average Analyst price target in the past 3 months is 24.95.

0JXZ Financial Forecast

EUR -5EUR -0.75EUR 3.5EUR 7.75EUR 12Q4 2025Q2 2026Q3 2026
HighEUR 0.23
ConsensusEUR -0.72
LowEUR -1.61

0JXZ Earnings Forecast

Next quarter’s earnings estimate for 0JXZ is -EUR 0.72 with a range of -EUR 1.61 to EUR 0.23. The previous quarter’s EPS was EUR 0.03. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.

EUR 849,999EUR 225.8MEUR 450.8MEUR 675.8MEUR 900.8MQ4 2025Q2 2026Q3 2026
HighEUR 11M
ConsensusEUR 6.46M
LowEUR 850K

0JXZ Sales Forecast

Next quarter’s sales forecast for 0JXZ is EUR 6.46M with a range of EUR 850.00K to EUR 11.00M. The previous quarter’s sales results were EUR 12.11M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.

0JXZ Stock Forecast FAQ

What is GB:0JXZ’s average 12-month price target, according to analysts?
Based on analyst ratings, Lakefront Biotherapeutics NV’s 12-month average price target is €24.95.
What is GB:0JXZ’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0JXZ, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Lakefront Biotherapeutics NV a Buy, Sell or Hold?
Lakefront Biotherapeutics NV has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 1 hold ratings and 1 sell ratings.
What is Lakefront Biotherapeutics NV’s share price target?
The average share price target for Lakefront Biotherapeutics NV is €24.95. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €27.90, and the lowest forecast is €22.00. The average share price target represents a 13.37% decrease from the current price of €28.8.
What do analysts say about Lakefront Biotherapeutics NV?
Lakefront Biotherapeutics NV’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Lakefront Biotherapeutics NV?
To buy shares of GB:0JXZ, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.